Rockwell Medical, Inc. (RMTI)
| Market Cap | 24.59M -32.1% |
| Revenue (ttm) | 72.58M -4.0% |
| Net Income | -5.81M |
| EPS | -1.47 |
| Shares Out | 4.03M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 30,086 |
| Open | 6.85 |
| Previous Close | 6.61 |
| Day's Range | 6.06 - 7.27 |
| 52-Week Range | 4.89 - 12.90 |
| Beta | 1.73 |
| Analysts | Buy |
| Price Target | 20.00 (+227.87%) |
| Earnings Date | Nov 12, 2026 |
About RMTI
Rockwell Medical, Inc., together with its subsidiaries, engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. It offers citrapure citric acid concentrate, dri-sate dry acid concentrate, renalpure liquid acid concentrate, dri-sate acid concentrate mixer, renalpure acid concentrate, renalpure bicarbonate concentrate, sterilyte bicarbonate concentrate, bicarbonate cartridges, and dry acid concentrate mixer, as well as ancillary products, including 5% acetic a... [Read more]
Financial Performance
In 2025, Rockwell Medical's revenue was $69.26 million, a decrease of -31.76% compared to the previous year's $101.49 million. Losses were -$5.47 million, 599.1% more than in 2024.
Financial StatementsAnalyst Summary
According to 2 analysts, the average rating for RMTI stock is "Buy." The 12-month stock price target is $20.0, which is an increase of 227.87% from the latest price.
News
Rockwell Medical Earnings Call Transcript: Q3 2026
Q3 sales rose 20% YoY, while gross margin improved to 16%; net loss included acquisition costs. Full-year guidance was withdrawn as integration planning began for the pending Vantive acquisition, expected to expand annual revenue to $400M–$450M after closing.
Rockwell Medical Earnings release: Q3 2026
Rockwell Medical released its Q3 2026 earnings on November 12, 2026, summarizing the period's financial results.
Rockwell Medical Quarterly report: Q3 2026
Rockwell Medical has published its Q3 2026 quarterly earnings report on November 12, 2026.
Rockwell Medical Announces Third Quarter 2026 Results
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical announces Q3'26 results, grew net sales 20% YoY reflecting strong customer adoption of our hemodialysis concentrates pr...
Rockwell Medical Transcript: M&A announcement
The acquisition adds Vantive’s global HD products, services, installed base, and manufacturing footprint, with combined annual sales projected at $400 million-$450 million and ~90% recurring. Closing is expected in mid-2027, subject to approvals and other conditions.
Rockwell Medical Press release: M&A announcement
Rockwell Medical issued a press release on November 3, 2026, disclosing material business information to investors.
Rockwell Medical Slides: M&A announcement
Rockwell Medical has posted slides in relation to its latest quarterly earnings report, which was published on November 3, 2026.
Rockwell Medical to acquire Vantive’s hemodialysis assets for $125M
Rockwell Medical (RMTI) announced that it has entered into an Equity and Asset Purchase Agreement with Vantive Limited. Subject to the terms of the Agreement, Rockwell Medical will acquire Vantive’s…
Rockwell Medical withdraws previously issued 2026 guidance
Rockwell Medical (RMTI) is withdrawing its previously issued 2026 guidance for Net Sales, Gross Margin, Adjusted EBITDA and Operating Cash Flow due to projected expenses related to expected transactio...
Vantive Announces Agreement to Divest Majority of Hemodialysis Assets and Associated Operations to Rockwell Medical
Sharpens Vantive's Focus on Home Dialysis and Critical Care DEERFIELD, Ill., Nov. 3, 2026 /PRNewswire/ -- Vantive, a vital organ therapy company with a 70-year legacy of kidney care innovation, today ...
Rockwell Medical Announces Transformational Global Hemodialysis Acquisition
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical is acquiring Vantive's HD concentrates, HD machines, water treatment systems, and related consumables and technical ser...
Rockwell Medical to Release Third Quarter 2026 Results on Thursday, November 12, 2026
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will release its results for the third quarter ended September 30, 2026 on Thursday, November 12, 2026.
Rockwell Medical to Exhibit at ASN Kidney Week 2026
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Come visit Rockwell Medical in Booth #1049 at ASN Kidney Week 2026 at the Colorado Convention Center in Denver, CO.
Rockwell Medical Ranked No. 16 on the 2026 Fortune ‘Best Workplaces in Manufacturing & Production' List
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--This marks the 3rd consecutive year that Rockwell Medical earned this recognition—climbing the ranks from #50 (2024) and #40 (2025) to #...
Rockwell Medical reports Q2 EPS (4c) vs. (7c) last year
Reports Q2 revenue $17.8M vs. $16.1M last year. “The momentum in our business continues to build. Our second quarter results reflect the outcome of the actions we have taken to…
Rockwell Medical sees 2026 revenue $70.0M-$75.0M vs. $69.26M in 2025
Sees 2026 adjusted EBITDA $1.0M-$2.0M.
Rockwell Medical Earnings Call Transcript: Q2 2026
Q2 2026 saw 11% net sales growth, margin expansion to 18%, and positive operating cash flow, driven by new customers, pricing, and operational efficiencies. Guidance for 2026 is reaffirmed, with continued investments in automation and a new medical device opportunity.
Rockwell Medical Earnings release: Q2 2026
Rockwell Medical released its Q2 2026 earnings on August 13, 2026, summarizing the period's financial results.
Rockwell Medical Quarterly report: Q2 2026
Rockwell Medical has published its Q2 2026 quarterly earnings report on August 13, 2026.
Rockwell Medical Slides: Q2 2026
Rockwell Medical has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 13, 2026.
Rockwell Medical Announces Second Quarter 2026 Results
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical announces Q2'26 results, delivering strong year-over-year growth, expanding gross margin and generating positive operat...
Rockwell Medical Advances Quality and Regulatory Leadership
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Brian Cox joins Rockwell Medical as VP, Quality and Regulatory Compliance, bringing more than 20 years' healthcare experience to the Com...
Rockwell Medical regains compliance with Nasdaq listing rules
Rockwell Medical (RMTI) announced that it has received notice from The Nasdaq Stock Market that the Company has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule…
Rockwell Medical Regains Compliance with Nasdaq Listing Requirements
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical received notice from Nasdaq that it regained compliance with the minimum bid price requirement under Nasdaq Listing Rul...
Rockwell Medical to Release Second Quarter 2026 Results on Thursday, August 13, 2026
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will release its results for the second quarter ended June 30, 2026 on Thursday, August 13, 2026.